Dupont creates new opportunities

The recent change in policy by Dupont with regard to the Oncomouse patent opens the door to academic-pharma collaboration.  It may also be possible to streamline development of novel drug testing by creating a non-profit company or organization for this specific purpose.  Rhabdomyosarcoma, Inc?  Would members of the community have interest in such an endeavor?